Ann: Partnership with OncoBay Clinical to advance CHM 1101, page-7

more a natural progression from getting FDA IND clearance on 20 August. Less than two weeks on, and we’ve finalised a collaboration to accelerate our phase 1 trial recruitment and making meaningful inroads into preparing for our phase 2 trial.

I personally like to focus on what the business is doing as opposed to the share price. Does a company enter into a collaboration like this to speed up recruitment if they have seen bad results thus far, or is it more likely they have they seen something (or lack of something) to give them confidence to proceed aggressively.